Abstract
Exposure to aflatoxin B1 (AFB1), an important cofactor in the etiology of hepatocellular carcinoma in Taiwan, is influenced by dietary and other factors. The present study examined the intraindividual variability in AFB1-albumin adducts, the most reliable long-term biomarker of AFB1 exposure, and whether the baseline or follow-up adduct levels and the intraindividual variability in adduct levels are modified by endogenous and environmental factors. The study measured AFB1-albumin adduct levels among 264 healthy male residents of three townships (Hu-Hsi, Ma-Kung, and Pai-Hsa) of Penghu Islets, Taiwan, at two different time points with a median interval of 1.68 years (range 1.00-3.17 years). There was a generalized reduction in the adduct levels, with the median values being 22.1 pmol/mg (range 5.0-355.8 pmol/mg) at time 1 and 14.3 pmol/mg (range 5.0-205.2 pmol/mg) at time 2. This intraindividual variability in adduct levels was inversely associated with the age of subjects and the time interval between the two blood draws. The variability in adduct levels was lower among subjects in Hu-Hsi and Pai-Hsa townships as compared to those in Ma-Kung. No significant association was observed for the intraindividual variability in AFB1-albumin adducts with regard to the season when blood was drawn. There was also no significant association between intraindividual variability and hepatitis B surface antigen, anti-hepatitis C virus (anti-HCV), glutathione S-transferase (GST) M1, or GSTT1 status. In conclusion, we found substantial intraindividual variability in the AFB1 exposure (as determined by AFB1-albumin adducts) in Taiwan, which was probably more likely related to dietary or other environmental influences rather than to endogenous factors (e.g., hepatitis B/C viral infection or GST M1/T1 genetic status).
Full Text
The Full Text of this article is available as a PDF (50.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bell D. A., Taylor J. A., Paulson D. F., Robertson C. N., Mohler J. L., Lucier G. W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst. 1993 Jul 21;85(14):1159–1164. doi: 10.1093/jnci/85.14.1159. [DOI] [PubMed] [Google Scholar]
- Chen C. J., Wang L. Y., Lu S. N., Wu M. H., You S. L., Zhang Y. J., Wang L. W., Santella R. M. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology. 1996 Jul;24(1):38–42. doi: 10.1002/hep.510240108. [DOI] [PubMed] [Google Scholar]
- Dickey C., Santella R. M., Hattis D., Tang D., Hsu Y., Cooper T., Young T. L., Perera F. P. Variability in PAH-DNA adduct measurements in peripheral mononuclear cells: implications for quantitative cancer risk assessment. Risk Anal. 1997 Oct;17(5):649–656. doi: 10.1111/j.1539-6924.1997.tb00905.x. [DOI] [PubMed] [Google Scholar]
- Gan L. S., Skipper P. L., Peng X. C., Groopman J. D., Chen J. S., Wogan G. N., Tannenbaum S. R. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis. 1988 Jul;9(7):1323–1325. doi: 10.1093/carcin/9.7.1323. [DOI] [PubMed] [Google Scholar]
- Makarananda K., Pengpan U., Srisakulthong M., Yoovathaworn K., Sriwatanakul K. Monitoring of aflatoxin exposure by biomarkers. J Toxicol Sci. 1998 Jul;23 (Suppl 2):155–159. doi: 10.2131/jts.23.supplementii_155. [DOI] [PubMed] [Google Scholar]
- Pemble S., Schroeder K. R., Spencer S. R., Meyer D. J., Hallier E., Bolt H. M., Ketterer B., Taylor J. B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994 May 15;300(Pt 1):271–276. doi: 10.1042/bj3000271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qian G. S., Ross R. K., Yu M. C., Yuan J. M., Gao Y. T., Henderson B. E., Wogan G. N., Groopman J. D. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):3–10. [PubMed] [Google Scholar]
- Sheabar F. Z., Groopman J. D., Qian G. S., Wogan G. N. Quantitative analysis of aflatoxin-albumin adducts. Carcinogenesis. 1993 Jun;14(6):1203–1208. doi: 10.1093/carcin/14.6.1203. [DOI] [PubMed] [Google Scholar]
- Wang J. S., Groopman J. D. DNA damage by mycotoxins. Mutat Res. 1999 Mar 8;424(1-2):167–181. doi: 10.1016/s0027-5107(99)00017-2. [DOI] [PubMed] [Google Scholar]
- Wang J. S., Qian G. S., Zarba A., He X., Zhu Y. R., Zhang B. C., Jacobson L., Gange S. J., Muñoz A., Kensler T. W. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):253–261. [PubMed] [Google Scholar]
- Wang L. Y., Hatch M., Chen C. J., Levin B., You S. L., Lu S. N., Wu M. H., Wu W. P., Wang L. W., Wang Q. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer. 1996 Sep 4;67(5):620–625. doi: 10.1002/(SICI)1097-0215(19960904)67:5<620::AID-IJC5>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
- Wild C. P., Garner R. C., Montesano R., Tursi F. Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis. 1986 Jun;7(6):853–858. doi: 10.1093/carcin/7.6.853. [DOI] [PubMed] [Google Scholar]
- Wild C. P., Yin F., Turner P. C., Chemin I., Chapot B., Mendy M., Whittle H., Kirk G. D., Hall A. J. Environmental and genetic determinants of aflatoxin-albumin adducts in the Gambia. Int J Cancer. 2000 Apr 1;86(1):1–7. doi: 10.1002/(sici)1097-0215(20000401)86:1<1::aid-ijc1>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]